Special Advisor, Japan Coverage
Japan Office | email@example.com
Masaki Doi is a Special Advisor on Japan Coverage at Torreya. Masaki has a deep and broad network in venture capital and biotechnology sectors. He also has a breadth of experiences in the areas of drug discovery and development and various kind of cross border transactions in the pharma industry. Formerly, he served as the President of Illumina Japan, where he has achieved 50% growth of NGS sales in the Japanese market during his tenure. Additionally, he spent 11 years at Astellas Pharma as Corporate Executive, Head of Global Business Development where he was involved in the Medivation license of Xtandi, a licensing agreement with FibroGen and acquisition of OSI Pharma. During this time, he also founded Astellas Venture Management, the venture capital arm of Astellas Pharma.
Masaki holds a Ph.D. in biochemistry, molecular biology and genetics from University of Tokyo. He has graduated Faculty of Science, Department of Biochemistry and Biophysics, University of Tokyo.